Avenue Therapeutics (ATXI) Misses Q2 EPS by 39c
Tweet
Share
E-mailGet Alerts ATXI Hot Sheet
Join SI Premium – FREE
Avenue Therapeutics (NASDAQ: ATXI) reported Q2 EPS of ($0.52), $0.39 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Avenue Therapeutics (ATXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
